Form 4 Tracker
Charles Schoch

Chief Financial Officer · 1 filing · Latest: Jan 26, 2026

Candel Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CADL
CHARLES SCHOCHMar 17, 2025
Proposed Sale
$8.755,000$43.8K
CADL
Schoch CharlesJan 15, 2025
Proposed Sale
$7.848,751$68.6K
CADL
Schoch CharlesJan 8, 2025
Proposed Sale
$8.359,801$81.8K